Neonatal Fetal Nutrition & Metabolism 2
Session: Neonatal Fetal Nutrition & Metabolism 2
Gregory C. Valentine, MD, MED, FAAP (he/him/his)
Associate Professor of Pediatrics, Division of Neonatology
University of Washington
Seattle, Washington, United States
Data is reported as median (interquartile range). P-values obtained via ANOVA.
Panels A-C: Unadjusted visual depictions via loess smooth plots of percent MWL (on a continuous scale) within the first week after birth and Bayley-3 cognitive (A), motor (B), and language (C) domain scores. Panels D-E: Box plots depicting the percent MWL category and Bayley-3 cognitive (D), motor (E), and language (F) domain scores with the point estimate and 95% confidence intervals from the adjusted models. There are no significant associations with percent MWL and 2-year corrected gestational age Bayley-3 cognitive, motor, or language domains. Covariates included in the adjustments included: Gestational age at birth, birthweight Z-score, intubation/chest compressions, mechanical ventilation need on day 1, average TFA category, treatment group within PENUT Trial, postnatal steroid use, postnatal vasopressor use, cumulative weight loss, time from nadir of weight loss to regain of birthweight (nadir-to-regain), and highest level of maternal education. Sensitivity analyses including those that died not shown.
Panels A-C: Unadjusted visual depictions via Loess smooth plots of average TFA within the first week after birth (on a continuous scale) and Bayley-3 cognitive (A), motor (B), and language (C) domain scores. Panels D-E: Box plots depicting the average TFA category and Bayley-3 cognitive (D), motor (E), and language (F) domain scores with the point estimate and 95% confidence intervals from the adjusted models written above each respective box plot. While the unadjusted analyses demonstrate a linear association between increasing average TFA and 2-year corrected gestational age Bayley-3 neurodevelopmental outcomes, the only significant findings after adjustment for confounders was a 3.4 point higher score in the 120- <150 mL/kg birthweight/day TFA group as compared to <120 mL/kg birthweight/day suggesting the clear linear trend in the unadjusted analyses is likely predominantly due to confounders related to severity of illness. Covariates included in the adjustments included: Gestational age at birth, birthweight Z-score, intubation/chest compressions, mechanical ventilation need on day 1, average percent MWL category, treatment group within PENUT Trial, postnatal steroid use, postnatal vasopressor use, cumulative weight loss, time from nadir of weight loss to regain of birthweight (nadir-to-regain), and highest level of maternal education. TFA category is based on average first week TFA in mL/kg birthweight/day. Sensitivity analyses including those that died not shown.